SureTrader Advertisement
Home > Boards > US OTC > Biotechs >

Caladrius Biosciences, Inc. (CLBS)

CLBS RSS Feed
Add CLBS Price Alert      Hide Sticky   Hide Intro
Moderator: Viperciara
Search This Board:
Last Post: 7/1/2016 4:20:09 PM - Followers: 96 - Board type: Free - Posts Today: 14
Company Name: Caladrius Biosciences
Company Type: Biotechnology
Ticker: CLBS
Stock Exchange: Nasdaq
Website: www.caladrius.com
Contact E-mail: info@caladrius.com
Address: 420 Lexington Avenue, Suite 350, NYC 10170
Mission: At Caladrius Biosciences, our mission is to bring new, innovative and treatment paradigm-changing medical therapies to market based on our unique expertise and experience, and in so doing, to improve patients’ lives and create value for our shareholders.
Executives
David J. Mazzo: Chief Executive Officer and Director
Robert S. Vaters: President, Chief Financial Officer and Director
Hans Kierstead: Senior Vice President, Research and Chief Science Officer
Douglas W. Losordo: Senior Vice President, Clinical, Medical and Regulatory Affairs               and Chief Medical Officer
Robert A. Preti; Senior Vice President, Development and Technical Operations and Chief Technology Officer
David Schloss; Vice President, Human Resources
Board of Directors
Robin L. Smith: Chairman
David J. Mazzo: Chief Executive Officer and Director
Robert S. Vaters: President, Chief Financial Officer and Director
Richard Berman: Director
Drew Bernstein:Director
Martyn D. Greenacre: Director
Steven M. Klosk: Director
Steven S. Meyers: Lead Director
Andrew L. Pecora: Chief Medical Officer- PCT, A Caladrius Company, and Director
Peter G. Traber; Director
Eric H.C. Wei: Director
 
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
CLBS
Current Price
Volume:
Bid Ask Day's Range
Advertisement
SureTrader
PostSubject
#2827   Have a happy fourth, stay safe. Catch you Tuesday. PROPHETABLE 07/01/16 04:20:09 PM
#2826   All good, Prophet. Happy to be wrong, akasidney86 07/01/16 04:19:32 PM
#2825   Thanks, I just see the bollie divergence which PROPHETABLE 07/01/16 04:15:34 PM
#2824   Prophetable, I certainly don't hope you're wrong, but akasidney86 07/01/16 04:12:55 PM
#2823   Yup! She's going .80+ short term more than IMO PROPHETABLE 07/01/16 04:01:28 PM
#2822   ;) breakout all aboard ;) stock1ace1 07/01/16 04:00:39 PM
#2821   150k on bid... ;-) PROPHETABLE 07/01/16 03:50:56 PM
#2820   within what time period ....... hbhmb 07/01/16 02:31:39 PM
#2819   Volume coming stock1ace1 07/01/16 12:54:44 PM
#2818   Yes watching stock1ace1 07/01/16 12:51:01 PM
#2817   This breaks .63 it goes .80+ imo PROPHETABLE 07/01/16 12:38:45 PM
#2816   chart , fart, the only thing that counts hbhmb 07/01/16 10:46:28 AM
#2815   ^ stock1ace1 07/01/16 08:41:23 AM
#2814   goes... where? akasidney86 07/01/16 08:38:15 AM
#2813   Looking at the chart I think this one PROPHETABLE 06/30/16 11:03:24 PM
#2812   been holding this since before Lincoln was president. hbhmb 06/30/16 08:27:05 PM
#2811   Read the 8k that was posted on the doin1 06/30/16 05:46:25 PM
#2810   Big volume today ~;) stock1ace1 06/30/16 01:20:58 PM
#2809   A buy out ? Where did u read stock1ace1 06/30/16 01:13:24 PM
#2808   akasidney86 06/30/16 10:15:32 AM
#2807   The perils of Pauline. We just passed akasidney86 06/30/16 10:15:04 AM
#2806   Looks like they are getting bought out boys!Read doin1 06/27/16 07:02:07 PM
#2805   You're hard to please, Virgil. First you akasidney86 06/27/16 05:57:07 PM
#2804   What kiddish replies, oh my...no wonder you spend Virgilio 06/27/16 05:19:32 PM
#2803   Caladrius Biosciences SVP and President of PCT, Robert Viperciara 06/27/16 09:40:51 AM
#2802   Virgilio: I speak fluent English, Spanish, and French, with akasidney86 06/27/16 04:00:10 AM
#2801   I am more than happy to do a Virgilio 06/26/16 02:04:02 PM
#2800   For openers, Virgilio, please pay attention to your akasidney86 06/26/16 09:29:57 AM
#2799   I am quite wordless from a similar answer, Virgilio 06/26/16 06:05:17 AM
#2798   Virgilio, I'm surprised that you'd be interested in akasidney86 06/26/16 05:52:02 AM
#2797   Since Kiadis' ATIR101 will initiate its PH3 trial Virgilio 06/25/16 01:40:16 PM
#2796   Virgilio, I assume that people paid to do akasidney86 06/23/16 02:52:52 PM
#2795   You miss the point that most likely they Virgilio 06/23/16 02:29:18 PM
#2794   You miss the point that most likely they Virgilio 06/23/16 02:29:16 PM
#2793   I'd call this statement: If they can akasidney86 06/23/16 11:10:33 AM
#2792   I admire your optimism. Virgilio 06/22/16 05:11:43 PM
#2791   Well, everybody loves winners, so with good results, akasidney86 06/22/16 02:33:26 PM
#2790   "BASKING RIDGE, N.J., (June 21, 2016) -- Caladrius F1ash 06/21/16 07:45:11 AM
#2789   So, 3 months after the Hitachi deal was Virgilio 06/20/16 05:10:45 PM
#2788   And, just to get an idea, where do Virgilio 06/18/16 01:59:39 PM
#2787   No, haven't, but what I'm more interested in akasidney86 06/18/16 06:10:08 AM
#2786   Did anyone hear anything about Japan yet? Virgilio 06/17/16 06:20:41 PM
#2785   LOL....more dilution??? andy e 06/07/16 06:09:50 PM
#2784   At least there's someone who finally puts down Virgilio 06/07/16 03:08:50 PM
#2783   Virgilio, when they went for OS as an akasidney86 06/07/16 07:17:42 AM
#2782   Actually I keep posting facts, I wonder why Virgilio 06/06/16 02:17:26 PM
#2781   It seems like you are one of the doin1 06/05/16 07:18:15 PM
#2780   Excessive optimism is at the base of failure Virgilio 06/05/16 05:35:16 PM
#2779   http://www.contractpharma.com/contents/view_breaking-news/2014-01-09/neostem-kit doin1 06/05/16 04:09:33 PM
#2778   PCT will benefit from this. doin1 06/05/16 03:36:50 PM
PostSubject